Catalyst for Expansion: Market Growth Drivers in 2026 The primary Ophthalmology Surgical Device Market growth driver in 2026 is the "Myopia Pandemic" affecting younger generations. With nearly 30% of the global population now suffering from high myopia, the demand for refractive surgical devices, such as SMILE (Small Incision Lenticule Extraction) and LASIK platforms, has surged. Additionally, the rise of "Premium IOLs"—including multifocal and toric lenses—is increasing the per-procedure revenue for clinics. Patients are increasingly willing to pay out-of-pocket for "spectacle independence," driving manufacturers to innovate in high-margin lens technology. https://www.marketresearchfuture.com/reports/ophthalmology-surgical-device-market-42258 Another major driver is the improvement in MIGS (Minimally Invasive Glaucoma Surgery) technology. Historically, glaucoma surgery was reserved for advanced cases due to risk; however, new microscopic stents and bypass tools allow surgeons to treat glaucoma during routine cataract surgery. This "Interventional Glaucoma" trend has opened a massive new market segment. Furthermore, government-backed vision screening programs in India and China are identifying millions of untreated cataract cases, creating a consistent, high-volume demand for entry-level surgical kits and consumables. FAQ: Question: What are MIGS devices? Answer: Minimally Invasive Glaucoma Surgery devices are microscopic implants or tools used to lower intraocular pressure with less trauma than traditional glaucoma surgery.